Katherine A High - Net Worth and Insider Trading

Katherine A High Net Worth

The estimated net worth of Katherine A High is at least $24 Million dollars as of 2024-03-28. Katherine A High is the See Remarks of Spark Therapeutics Inc and owns about 210,000 shares of Spark Therapeutics Inc (ONCE) stock worth over $24 Million. Details can be seen in Katherine A High's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Katherine A High has not made any transactions after 2017-11-28 and currently still holds the listed stock(s).

Transaction Summary of Katherine A High

To

Katherine A High Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Katherine A High owns 3 companies in total, including CRISPR Therapeutics AG () , Incyte Corp () , and Spark Therapeutics Inc () .

Click here to see the complete history of Katherine A High’s form 4 insider trades.

Insider Ownership Summary of Katherine A High

Ticker Comapny Transaction Date Type of Owner
CRISPR Therapeutics AG 2019-06-11 director
Incyte Corp 2020-03-26 director
Spark Therapeutics Inc 2019-12-17 director & See Remarks

Katherine A High Latest Holdings Summary

Katherine A High currently owns a total of 1 stock. Katherine A High owns 210,000 shares of Spark Therapeutics Inc (ONCE) as of November 28, 2017, with a value of $24 Million.

Latest Holdings of Katherine A High

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ONCE Spark Therapeutics Inc 2017-11-28 210,000 113.57 23,849,700

Holding Weightings of Katherine A High


Katherine A High Form 4 Trading Tracker

According to the SEC Form 4 filings, Katherine A High has made a total of 0 transactions in Spark Therapeutics Inc (ONCE) over the past 5 years. The most-recent trade in Spark Therapeutics Inc is the sale of 5,000 shares on November 28, 2017, which brought Katherine A High around $356,600.

Insider Trading History of Katherine A High

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Katherine A High Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Katherine A High Ownership Network

Ownership Network List of Katherine A High

No Data

Ownership Network Relation of Katherine A High


Katherine A High Owned Company Details

What does CRISPR Therapeutics AG do?

Who are the key executives at CRISPR Therapeutics AG?

Katherine A High is the director of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Financial Officer Raju Prasad , Chief Business Officer Samarth Kulkarni , and General Counsel and Secretary James R. Kasinger .

CRISPR Therapeutics AG () Insider Trades Summary

Over the past 18 months, Katherine A High made no insider transaction in CRISPR Therapeutics AG (). Other recent insider transactions involving CRISPR Therapeutics AG () include a net sale of 330,755 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .

In summary, during the past 3 months, insiders sold 140,139 shares of CRISPR Therapeutics AG () in total and bought 0 shares, with a net sale of 140,139 shares. During the past 18 months, 340,139 shares of CRISPR Therapeutics AG () were sold and 0 shares were bought by its insiders, resulting in a net sale of 340,139 shares.

CRISPR Therapeutics AG ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CRISPR Therapeutics AG Insider Transactions

No Available Data

Katherine A High Mailing Address

Above is the net worth, insider trading, and ownership report for Katherine A High. You might contact Katherine A High via mailing address: 3737 Market Street, Suite 1300, Philadelphia Pa 19104.

Discussions on Katherine A High

No discussions yet.